Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Analysis: New drugs drive prostate cancer market
Yahoo/AP
Monday, September 19, 2011 - 6:08pm
tags:
prostate cancer, Dendreon, Exelixis, JNJ, MDV3100, Medivation, Provenge, cabozatinib, Zytiga
Those Merck Layoffs Are Imminent For Some
Pharmalot
Monday, September 19, 2011 - 6:02pm
tags:
Merck, layoffs
Momenta shares fall more than 24% on rival's FDA approval
Bizjournals.com
Monday, September 19, 2011 - 6:01pm
tags:
Momenta, FDA, Sanofi, Lovenox, Amphastar, Novartis, Sandoz
Gilead Quad HIV Drug Meets Second Study Goal
TheStreet.com
Monday, September 19, 2011 - 6:00pm
tags:
HIV, Gilead, Quad
Novo Nordisk Presents Degludec Data
Yahoo/Zacks.com
Monday, September 19, 2011 - 5:59pm
tags:
Novo Nordisk, degludec, Sanofi, insulin, diabetes
Amgen Wins Expanded U.S. Approval for Bone-Strengthening Drug
Bloomberg
Monday, September 19, 2011 - 12:18pm
tags:
FDA, Amgen, Prolia, prostate cancer, breast cancer
Teva Strengthens Its Innovation Pipeline
Seeking Alpha
Monday, September 19, 2011 - 12:16pm
tags:
Teva Pharmaceuticals, Cocrystal Discovery, CureTech, innovation
Novartis Confirms: There Will Be “Downsizing”
BNET Pharma
Monday, September 19, 2011 - 12:09pm
tags:
Novartis, layoffs
Momenta Hit on Approval of Blood Thinner Rival
TheStreet.com
Monday, September 19, 2011 - 12:09pm
tags:
Momenta, bloodthinners, Lovenox, generics, Sanofi, Amphastar, Sandoz, Novartis
Why Merck May Be About to Take Off
Motley Fool
Monday, September 19, 2011 - 12:08pm
tags:
Merck, Abbott Laboratories, Bristol-Myers Squibb, Allergan
Is Novartis a Cash King?
Motley Fool
Monday, September 19, 2011 - 12:07pm
tags:
Novartis
Bristol-Myers Pegged as Takeover Target
WSJ Online
Monday, September 19, 2011 - 12:05pm
tags:
M&A, Bristol-Myers Squibb, Pfizer
Merck's Competitive Advantage: Buy And Hold, But Sell If Necessary
Seeking Alpha
Monday, September 19, 2011 - 11:08am
tags:
Merck, Vertex
Ampio Pharmaceuticals On A Roll With New Licensing Agreement
Seeking Alpha
Sunday, September 18, 2011 - 12:17pm
tags:
Ampio Pharmaceuticals, Zertane, pain management, premature ejaculation, Daewoong Pharmaceuticals
Tylenol Supplies Low for Flu Season
WSJ
Sunday, September 18, 2011 - 12:14pm
tags:
Tylenol, JNJ, recalls
BMS-790052 Plus Peginterferon Alfa and Ribavirin Demonstrated up to 83% Sustained Virologic Response 24 Weeks Post-Treatment (SVR24) in Phase II Study of Genotype 1 Hepatitis C Patients
Yahoo/BusinessWire
Sunday, September 18, 2011 - 12:14pm
tags:
Bristol-Myers Squibb, BMS-790052, Peginterferon Alfa, Ribavirin, hepatitis C
The Next Big Thing in Biotech: Sangamo (video)
The Street
Sunday, September 18, 2011 - 12:10pm
tags:
Sangamo BioSciences
7 Possible Biotech Takeover Targets
Seeking Alpha
Sunday, September 18, 2011 - 12:02pm
tags:
Human Genome Sciences, Vertex Pharmaceuticals, Lexicon Pharmaceuticals, Amarin, Exelixis, Dendreon, Acorda Therapeutics
Raptor Pharma rises as analyst gives top rating
BusinessWeek
Saturday, September 17, 2011 - 5:22pm
tags:
DR Cystamine, Raptor Pharmaceuticals, cystinosis
FDA calls for tighter pharmaceutical supply chain
Supply Chain Digital
Saturday, September 17, 2011 - 5:03pm
tags:
FDA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.